| Metric | შპს ჯი-ი-ეს-ეი ფარმაცევტიკალს | შპს საფ ფარმა |
|---|---|---|
| Growth | ||
| Revenue | ₾5.7m₾5.5m | ₾6.4m₾6.5m |
| Revenue growth | 2.4% | -1.3% |
| Profitability | ||
| EBITDA | ₾2.7m₾1.6m | ₾1.4m₾1.2m |
| EBITDA margin | 48.1%29.8% | 22.5%18.4% |
| Net profit | ₾2.6m₾1.6m | ₾1.5m₾1.1m |
| Net margin | 46.4%29.8% | 23.0%17.7% |
| Balance sheet | ||
| Total assets | ₾13.5m₾10.6m | ₾5.3m₾5.4m |
| Total equity | ₾11.7m₾9.1m | ₾2.7m₾1.2m |
| ROE | 22.4%18.1% | 54.6%93.9% |